Hospital Clínic Barcelona’s Diabetes Unit has been qualified by the European INNODIA network as a clinical trial site (CTS), which will allow it to p1
This program aims to decipher the mechanisms underlying metabolic diseases through molecular and systemic studies, analyse interactions between organ1
They are Metabolism and disease programme (MetaDis) and Translational research programme for brain disorders
This is confirmed by a study conducted by IDIBAPS-Hospital Clínic Barcelona and IDIAPJGol and published in the journal Frontiers in Endocrinology.&nb1
As one of its many initiatives, the Diabetes Unit is implementing a scorecard to segment patients with diabetes and offer more efficient treatment at1
